Related Experiment Videos
[Fetal DNA in maternal blood]
R J Rijnders1, G C Christiaens, M de Haas
1Universitair Medisch Centrum Utrecht, divisie Perinatologie en Gynaecologie, KE 04.123.1, Postbus 85.090, 3508 AB Utrecht. r_rijnders@hotmail.com
Nederlands Tijdschrift Voor Geneeskunde
|February 21, 2004
Summary
Non-invasive prenatal diagnosis using fetal DNA in maternal blood offers high accuracy for fetal sex determination and RhD genotyping. This approach can significantly reduce the need for invasive procedures and optimize treatment for certain fetal conditions.
Area of Science:
- Molecular Biology
- Genetics
- Obstetrics
Context:
- Fetal cells and cell-free fetal DNA (cffDNA) are present in maternal circulation.
- Traditional prenatal diagnosis often involves invasive procedures with associated risks.
- Advances in real-time polymerase chain reaction (PCR) enable sensitive detection and quantification of fetal DNA in maternal blood.
Purpose:
- To evaluate the utility of non-invasive fetal DNA analysis from maternal blood for prenatal diagnosis.
- To assess the accuracy of fetal sex determination using Y-chromosome PCR.
- To determine the efficacy of non-invasive RhD genotyping in RhD-negative women.
Summary:
- Real-time PCR techniques allow for the identification and quantification of fetal DNA in maternal blood.
- Fetal sex determination via Y-chromosome PCR demonstrates 100% specificity and high sensitivity, increasing with gestational age, potentially reducing invasive prenatal diagnosis for X-linked diseases by 50%.
- Non-invasive fetal RhD genotyping shows 100% sensitivity and specificity, rendering anti-D immunoprophylaxis unnecessary for RhD-negative mothers with RhD-negative fetuses.
Impact:
- Enables early, non-invasive fetal sexing to guide management of conditions like congenital adrenal hyperplasia, reducing maternal dexamethasone use.
- Minimizes the need for invasive prenatal diagnostic procedures, thereby reducing risks to the fetus and mother.
- Paves the way for detecting a wider range of inherited disorders non-invasively from maternal plasma, with ongoing research into conditions like preterm labor, pre-eclampsia, and aneuploidy.